These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16281934)

  • 21. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.
    Khan NI; Bradstock KF; Bendall LJ
    Br J Haematol; 2007 Aug; 138(3):338-48. PubMed ID: 17614820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation.
    Chiaretti S; Li X; Gentleman R; Vitale A; Wang KS; Mandelli F; Foà R; Ritz J
    Clin Cancer Res; 2005 Oct; 11(20):7209-19. PubMed ID: 16243790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Building better therapy for children with acute lymphoblastic leukemia.
    Carroll WL; Raetz EA
    Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
    Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
    Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.
    Estes DA; Lovato DM; Khawaja HM; Winter SS; Larson RS
    Br J Haematol; 2007 Oct; 139(1):20-30. PubMed ID: 17854304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.
    Talby L; Chambost H; Roubaud MC; N'Guyen C; Milili M; Loriod B; Fossat C; Picard C; Gabert J; Chiappetta P; Michel G; Schiff C
    Leuk Res; 2006 Jun; 30(6):665-76. PubMed ID: 16297978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.
    Meleshko AN; Belevtsev MV; Savitskaja TV; Potapnev MP
    Leuk Res; 2006 Jul; 30(7):795-800. PubMed ID: 16386788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of interleukin-10 splicing variants is a positive prognostic feature in relapsed childhood acute lymphoblastic leukemia.
    Wu S; Gessner R; Taube T; von Stackelberg A; Henze G; Seeger K
    J Clin Oncol; 2005 May; 23(13):3038-42. PubMed ID: 15860861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.
    Matsushita C; Yang Y; Takeuchi S; Matsushita M; Van Dongen JJ; Szczepanski T; Bartram CR; Seo H; Koeffler HP; Taguchi H
    Oncol Rep; 2004 Jul; 12(1):97-9. PubMed ID: 15201966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WT1 protein expression in childhood acute leukemia.
    Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
    Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the MDR1 gene expression after short-term ex vivo therapy with prednisolone have prognostic impact in childhood acute lymphoblastic leukemia.
    Janiszewska H; Styczynski J; Kolodziej B; Wysocki M; Haus O
    Ann Hematol; 2009 Dec; 88(12):1193-8. PubMed ID: 19352661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow Th2 cytokine expression as predictor for relapse in childhood acute lymphoblastic leukemia (ALL).
    Stachel D; Albert M; Meilbeck R; Kreutzer B; Haas RJ; Schmid I
    Eur J Med Res; 2006 Mar; 11(3):102-13. PubMed ID: 16751110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
    Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
    Meier M; den Boer ML; Hall AG; Irving JA; Passier M; Minto L; van Wering ER; Janka-Schaub GE; Pieters R
    Leukemia; 2005 Nov; 19(11):1887-95. PubMed ID: 16167060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
    Cario G; Fetz A; Bretscher C; Möricke A; Schrauder A; Stanulla M; Schrappe M
    Ann Hematol; 2008 Sep; 87(9):709-16. PubMed ID: 18521602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
    Juric D; Lacayo NJ; Ramsey MC; Racevskis J; Wiernik PH; Rowe JM; Goldstone AH; O'Dwyer PJ; Paietta E; Sikic BI
    J Clin Oncol; 2007 Apr; 25(11):1341-9. PubMed ID: 17312329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
    Cario G; Izraeli S; Teichert A; Rhein P; Skokowa J; Möricke A; Zimmermann M; Schrauder A; Karawajew L; Ludwig WD; Welte K; Schünemann HJ; Schlegelberger B; Schrappe M; Stanulla M
    J Clin Oncol; 2007 Oct; 25(30):4813-20. PubMed ID: 17947730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia.
    De Pittà C; Tombolan L; Campo Dell'Orto M; Accordi B; te Kronnie G; Romualdi C; Vitulo N; Basso G; Lanfranchi G
    Haematologica; 2005 Jul; 90(7):890-8. PubMed ID: 15996926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.
    Mussolin L; Pillon M; Conter V; Piglione M; Lo Nigro L; Pierani P; Micalizzi C; Buffardi S; Basso G; Zanesco L; Rosolen A
    J Clin Oncol; 2007 Nov; 25(33):5254-61. PubMed ID: 18024872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia.
    De Moerloose B; Swerts K; Benoit Y; Laureys G; Loeys T; Philippé J; Dhooge C
    Pediatr Hematol Oncol; 2003; 20(5):381-91. PubMed ID: 12775536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.